Item
1. CONSOLIDATED FINANCIAL STATEMENTS
MANHATTAN
BRIDGE CAPITAL, INC. AND SUBSIDIARIES
CONSOLIDATED
BALANCE SHEETS
|
|
September
30, 2017
|
|
|
December
31, 2016
|
|
|
|
(unaudited)
|
|
|
(audited)
|
|
Assets
|
|
|
|
|
|
|
Loans
receivable
|
|
$
|
44,419,950
|
|
|
$
|
34,755,320
|
|
Interest
receivable on loans
|
|
|
508,342
|
|
|
|
346,519
|
|
Cash
and cash equivalents
|
|
|
112,184
|
|
|
|
96,299
|
|
Deferred
financing costs
|
|
|
60,250
|
|
|
|
56,193
|
|
Investment
in privately held company
|
|
|
15,000
|
|
|
|
35,000
|
|
Other
assets
|
|
|
58,384
|
|
|
|
44,193
|
|
Total
assets
|
|
$
|
45,174,110
|
|
|
$
|
35,333,524
|
|
Liabilities
and Stockholders’ Equity
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
Line of credit
|
|
$
|
16,174,495
|
|
|
$
|
6,482,848
|
|
Senior
secured notes (net of deferred financing costs of $641,355 and $697,669, respectively)
|
|
|
5,358,645
|
|
|
|
5,302,331
|
|
Deferred
origination fees
|
|
|
390,743
|
|
|
|
315,411
|
|
Accounts
payable and accrued expenses
|
|
|
130,270
|
|
|
|
105,541
|
|
Dividends
payable
|
|
|
-
|
|
|
|
813,503
|
|
Total
liabilities
|
|
|
22,054,153
|
|
|
|
13,019,634
|
|
Commitments
and contingencies
|
|
|
|
|
|
|
|
|
Stockholders’
equity:
|
|
|
|
|
|
|
|
|
Preferred
shares - $.01 par value; 5,000,000 authorized; none issued
|
|
|
-
|
|
|
|
-
|
|
Common
shares - $.001 par value; 25,000,000 authorized; 8,319,036 and 8,312,036 issued; 8,108,934 and 8,135,036 outstanding, respectively
|
|
|
8,319
|
|
|
|
8,312
|
|
Additional
paid-in capital
|
|
|
23,164,245
|
|
|
|
23,134,013
|
|
Treasury
stock, at cost – 210,102 and 177,000 shares, respectively
|
|
|
(541,491
|
)
|
|
|
(369,335
|
)
|
Retained
earnings (Accumulated deficit)
|
|
|
488,884
|
|
|
|
(459,100
|
)
|
Total
stockholders’ equity
|
|
|
23,119,957
|
|
|
|
22,313,890
|
|
Total
liabilities and stockholders’ equity
|
|
$
|
45,174,110
|
|
|
$
|
35,333,524
|
|
The
accompanying notes are an integral part of these consolidated financial statements.
MANHATTAN
BRIDGE CAPITAL, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF OPERATIONS
(unaudited)
|
|
Three
Months
Ended
September 30,
|
|
|
Nine
Months
Ended
September 30,
|
|
|
|
2017
|
|
|
2016
|
|
|
2017
|
|
|
2016
|
|
Interest
income from loans
|
|
$
|
1,351,788
|
|
|
$
|
960,274
|
|
|
$
|
3,646,535
|
|
|
$
|
2,848,516
|
|
Origination
fees
|
|
|
239,675
|
|
|
|
208,951
|
|
|
|
675,434
|
|
|
|
591,191
|
|
Total
revenue
|
|
|
1,591,463
|
|
|
|
1,169,225
|
|
|
|
4,321,969
|
|
|
|
3,439,707
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
and amortization of debt service costs
|
|
|
352,359
|
|
|
|
205,449
|
|
|
|
861,591
|
|
|
|
593,749
|
|
Referral
fees
|
|
|
750
|
|
|
|
2,263
|
|
|
|
2,951
|
|
|
|
5,525
|
|
General
and administrative expenses
|
|
|
266,534
|
|
|
|
236,972
|
|
|
|
842,520
|
|
|
|
698,356
|
|
Total
operating costs and expenses
|
|
|
619,643
|
|
|
|
444,684
|
|
|
|
1,707,062
|
|
|
|
1,297,630
|
|
Income
from operations
|
|
|
971,820
|
|
|
|
724,541
|
|
|
|
2,614,907
|
|
|
|
2,142,077
|
|
Loss
on write-down of investment in privately held company (Note 4)
|
|
|
(10,000
|
)
|
|
|
-
|
|
|
|
(20,000
|
)
|
|
|
(10,000
|
)
|
Income
before income tax expense
|
|
|
961,820
|
|
|
|
724,541
|
|
|
|
2,594,907
|
|
|
|
2,132,077
|
|
Income
tax expense
|
|
|
(1,099
|
)
|
|
|
-
|
|
|
|
(2,971
|
)
|
|
|
(2,146
|
)
|
Net
income
|
|
$
|
960,721
|
|
|
$
|
724,541
|
|
|
$
|
2,591,936
|
|
|
$
|
2,129,931
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
and diluted net income per common share outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-Basic
|
|
$
|
0.12
|
|
|
$
|
0.10
|
|
|
$
|
0.32
|
|
|
$
|
0.29
|
|
-Diluted
|
|
$
|
0.12
|
|
|
$
|
0.10
|
|
|
$
|
0.32
|
|
|
$
|
0.29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average number of common shares outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-Basic
|
|
|
8,106,499
|
|
|
|
7,598,626
|
|
|
|
8,120,091
|
|
|
|
7,407,787
|
|
-Diluted
|
|
|
8,117,151
|
|
|
|
7,623,635
|
|
|
|
8,131,400
|
|
|
|
7,426,165
|
|
The
accompanying notes are an integral part of these consolidated financial statements.
MANHATTAN
BRIDGE CAPITAL, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(unaudited)
|
|
Nine
Months
|
|
|
|
Ended
September 30,
|
|
|
|
2017
|
|
|
2016
|
|
Cash
flows from operating activities:
|
|
|
|
|
|
|
|
|
Net
Income
|
|
$
|
2,591,936
|
|
|
$
|
2,129,931
|
|
Adjustments
to reconcile net income to net cash provided by
operating activities -
|
|
|
|
|
|
|
|
|
Amortization
of deferred financing costs
|
|
|
95,378
|
|
|
|
51,474
|
|
Depreciation
|
|
|
3,398
|
|
|
|
2,752
|
|
Non
cash compensation expense
|
|
|
9,798
|
|
|
|
10,192
|
|
Loss
on write-down of investment in privately held company (Note 4)
|
|
|
20,000
|
|
|
|
10,000
|
|
Changes
in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Interest
receivable on loans
|
|
|
(161,823
|
)
|
|
|
78,234
|
|
Other
assets
|
|
|
(15,922
|
)
|
|
|
(16,809
|
)
|
Accounts
payable and accrued expenses
|
|
|
24,730
|
|
|
|
(27,702
|
)
|
Deferred
origination fees
|
|
|
75,332
|
|
|
|
64,879
|
|
Net
cash provided by operating activities
|
|
|
2,642,827
|
|
|
|
2,302,951
|
|
|
|
|
|
|
|
|
|
|
Cash
flows from investing activities:
|
|
|
|
|
|
|
|
|
Issuance
of short term loans
|
|
|
(30,314,500
|
)
|
|
|
(24,299,500
|
)
|
Collections
received from loans
|
|
|
20,649,870
|
|
|
|
23,671,720
|
|
Purchase
of fixed assets
|
|
|
(1,666
|
)
|
|
|
(3,019
|
)
|
Net
cash used in investing activities
|
|
|
(9,666,296
|
)
|
|
|
(630,799
|
)
|
|
|
|
|
|
|
|
|
|
Cash
flows from financing activities:
|
|
|
|
|
|
|
|
|
Proceeds
from (repayments of) line of credit, net
|
|
|
9,691,647
|
|
|
|
(7,558,044
|
)
|
Repayments
of short-term loans, net
|
|
|
-
|
|
|
|
(1,095,620
|
)
|
Cash
restricted for reduction of line of credit
|
|
|
-
|
|
|
|
(919,352
|
)
|
Proceeds
from public offerings, net
|
|
|
-
|
|
|
|
9,539,347
|
|
Deferred
financing costs
|
|
|
(43,122
|
)
|
|
|
-
|
|
Proceeds
from exercise of stock options and warrants
|
|
|
20,440
|
|
|
|
305,004
|
|
Purchase
of treasury shares
|
|
|
(172,156
|
)
|
|
|
-
|
|
Dividends
paid
|
|
|
(2,457,455
|
)
|
|
|
(1,891,804
|
)
|
Net
cash provided by (used in) financing activities
|
|
|
7,039,354
|
|
|
|
(1,620,469
|
)
|
|
|
|
|
|
|
|
|
|
Net
increase in cash and cash equivalents
|
|
|
15,885
|
|
|
|
51,683
|
|
Cash
and cash equivalents, beginning of period
|
|
|
96,299
|
|
|
|
106,836
|
|
Cash
and cash equivalents, end of period
|
|
$
|
112,184
|
|
|
$
|
158,519
|
|
|
|
|
|
|
|
|
|
|
Supplemental
Cash Flow Information:
|
|
|
|
|
|
|
|
|
Taxes
paid during the period
|
|
$
|
2,971
|
|
|
$
|
1,948
|
|
Interest
paid during the period
|
|
$
|
713,428
|
|
|
$
|
546,015
|
|
The
accompanying notes are an integral part of these consolidated financial statements.
MANHATTAN
BRIDGE CAPITAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2017
1.
THE COMPANY
The
accompanying unaudited consolidated financial statements of Manhattan Bridge Capital, Inc. (“MBC”), a New York corporation
founded in 1989, and its consolidated subsidiaries, DAG Funding Solutions, Inc. (dissolved in September 2016) (“DAG Funding”),
a New York corporation formed in May 2007, and MBC Funding II Corp. (“MBC Funding II”), a New York corporation formed
in December 2015 (collectively referred to herein as the “Company”) have been prepared by the Company in accordance
with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with instructions
to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.
However, in the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair
presentation have been included. The accompanying unaudited consolidated financial statements should be read in conjunction with
the Company’s audited consolidated financial statements for the year ended December 31, 2016 and the notes thereto included
in the Company’s Annual Report on Form 10-K. Results of consolidated operations for the interim period are not necessarily
indicative of the operating results to be attained in the entire fiscal year.
The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amount of revenues and expenses during the reporting period. Actual amounts could differ
from those estimates.
The
consolidated financial statements include the accounts of MBC, DAG Funding (until its dissolution) and MBC Funding II. All significant
intercompany balances and transactions have been eliminated in consolidation.
The
Company offers short-term, secured, non–banking loans to real estate investors (also known as hard money) to fund their
acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan
area.
The
Company recognizes revenues in accordance with Accounting Standards Codification (“ASC”) 605, “Revenue Recognition”,
which provides guidance on the recognition, presentation and disclosure of revenue in financial statements. ASC 605 outlines the
basic criteria that must be met to recognize revenue and provides guidance for disclosure related to revenue recognition policies.
In general, the Company recognizes revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery of the product
has occurred or services have been rendered, (iii) the sales price charged is fixed or determinable, and (iv) collectability is
reasonably assured.
Interest
income from commercial loans is recognized, as earned, over the loan period.
Origination
fee revenue on commercial loans is amortized over the term of the respective note.
The
Company presents deferred financing costs, excluding those incurred in connection with its line of credit, in the balance sheet
as a direct reduction from the related debt liability rather than an asset, in accordance with Accounting Standards Update (“ASU”)
2015-03, “Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs”.
These costs, incurred in connection with the issuance of the Company’s senior secured notes, are being amortized over ten
years, using the straight-line method.
Deferred
financing costs in connection with the Company’s Credit and Security Agreement with Webster Business Credit Corporation
(“Webster”) as well as the Amended and Restated Credit and Security Agreement (“Amended Credit Agreement”)
with Webster and Flushing Bank (“Flushing”), pursuant to which the Company may borrow up to $20 million (the “Webster
Credit Line”), as discussed in Note 7, are presented as an asset in the balance sheet, in accordance with ASU 2015-15, “Interest
– Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated With
Line of Credit Arrangements”. These costs are being amortized over the term of the respective agreement, using the straight-line
method.
2.
RECENT TECHNICAL ACCOUNTING PRONOUNCEMENTS
In
November 2016, the Financial Accounting Standards Board (the “FASB”) issued ASU 2016-18, “Statement of Cash
Flows (Topic 230): Restricted Cash - a consensus of the FASB Emerging Issues Task Force.” The ASU requires that restricted
cash and restricted cash equivalents be included as components of total cash and cash equivalents as presented on the statement
of cash flows. For public companies that file with the SEC, the standard is effective for financial statements issued for fiscal
years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of this guidance is not expected
to have a material impact on the Company’s consolidated financial statements.
In
May 2017, the FASB issued ASU 2017-09, “Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting.”
The ASU provides guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity
would be required to apply modification accounting under ASC 718. Under the new guidance, modification accounting is required
only if the fair value, the vesting conditions, or the classification of the award changes as a result of the change in terms
or conditions. For all entities, the standard is effective for financial statements issued for fiscal years beginning after December
15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period.
The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements.
In
August 2017, the FASB issued ASU 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for
Hedging Activities.” The ASU expands the activities that qualify for hedge accounting and simplifies the rules for reporting
hedging transactions. For public companies that file with the SEC, the standard is effective for financial statements issued for
fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The
adoption of this guidance is not expected to have a material impact on the Company’s financial statements.
Management
does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a
material effect on the Company’s consolidated financial statements.
3.
COMMERCIAL LOANS
Loans
Receivable
The
Company offers short-term secured non–banking loans to real estate investors (also known as hard money) to fund their acquisition
and construction of properties located in the New York Metropolitan area. The loans are principally secured by collateral consisting
of first mortgage positions on real estate properties and, generally, accompanied by personal guarantees from the principals of
the borrowers. The loans are generally for a term of one year. The loans are initially recorded, and carried thereafter, in the
financial statements at cost. Most of the loans provide for receipt of interest only during the term of the loan and a balloon
payment at the end of the term.
At
September 30, 2017, we were committed to an additional $5,345,500 in construction loans that can be drawn by the borrowers when
certain conditions are met.
At
September 30, 2017, no one entity has loans outstanding representing more than 10% of the total balance of the loans outstanding.
The
Company generally grants loans for a term of one year. When a performing loan reaches its maturity, and the borrower requests
an extension, we may extend the term of the loan beyond one year. Prior to granting an extension of any loan, we reevaluate the
underlying collateral.
Credit
Risk
Credit
risk profile based on loan activity as of September 30, 2017:
Performing
loans
|
|
Developers-
Residential
|
|
|
Developers-
Commercial
|
|
|
Developers-
Mixed Used
|
|
|
Total
outstanding loans
|
|
September
30, 2017
|
|
$
|
40,659,950
|
|
|
$
|
750,000
|
|
|
$
|
3,010,000
|
|
|
$
|
44,419,950
|
|
At
September 30, 2017, the Company’s loans receivable includes loans in the amount of $345,000, $412,450 and $4,112,500 originally
due in 2014, 2015 and 2016, respectively. In all instances the borrowers are currently paying their interest and, generally, the
Company receives a fee in connection with the extension of the loans. Accordingly, at September 30, 2017, no loan impairments
exist and there are no provisions for impairments of loans or recoveries thereof included in operations.
Subsequent
to the balance sheet date, $1,343,450 of the loans receivable at September 30, 2017 were paid off.
4.
Investment in Privately Held Company
The
Company had an original investment in a privately held Israeli-based company in the amount of $100,000. The privately held company
offers surgeons and radiologists the ability to detect cancer in real time. Due to the fact that the privately held company has
experienced delays in executing its business plan, the Company determined to write down the value of its investment to $65,000
at December 31, 2013, to $50,000 at June 30, 2015, and to $35,000 at December 31, 2016. The Company further wrote down the value
of its investment to $25,000 at June 30, 2017 and to $15,000 at September 30, 2017, resulting in a charge to the statement of
operations of $10,000 and $20,000, respectively, for the three and nine month periods ended September 30, 2017.
5.
EARNINGS PER SHARE OF COMMON STOCK
Basic
and diluted earnings per share are calculated in accordance with ASC 260, “Earnings Per Share”. Under ASC 260, basic
earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares
outstanding for the period. The computation of diluted earnings per share is similar to basic earnings per share, except that
the denominator is increased to include the potential dilution from the exercise of stock options and warrants for common shares
using the treasury stock method. The numerator in calculating both basic and diluted earnings per common share for each period
is the reported net income.
The
denominator is based on the following weighted average number of common shares:
|
|
Three
Months
Ended September 30,
|
|
|
Nine
Months
Ended September 30,
|
|
|
|
2017
|
|
|
2016
|
|
|
2017
|
|
|
2016
|
|
Basic
|
|
|
8,106,499
|
|
|
|
7,598,626
|
|
|
|
8,120,091
|
|
|
|
7,407,787
|
|
Incremental
shares for assumed conversion of options
|
|
|
10,652
|
|
|
|
25,009
|
|
|
|
11,309
|
|
|
|
18,378
|
|
Diluted
|
|
|
8,117,151
|
|
|
|
7,623,635
|
|
|
|
8,131,400
|
|
|
|
7,426,165
|
|
For
the three and nine month periods ended September 30, 2017, 59,991 and 59,334, exercisable stock options and warrants were not
included in the diluted earnings per share calculation, respectively, because their effect would have been anti-dilutive.
For
the three and nine month periods ended September 30, 2016, 47,309 and 53,940, exercisable stock options and warrants were not
included in the diluted earnings per share calculation, respectively, because their effect would have been anti-dilutive.
6.
STOCK – BASED COMPENSATION
The
Company measures and recognizes compensation awards for all stock option grants made to employees and directors, based on their
fair value in accordance with ASC 718 “Compensation - Stock Compensation”, which establishes standards for the accounting
for transactions in which an entity exchanges its equity instruments for goods or services. A key provision of this statement
is to measure the cost of employee services received in exchange for an award of equity instruments (including stock options)
based on the grant-date fair value of the award. The cost will be recognized over the service period during which an employee
is required to provide service in exchange for the award (i.e., the requisite service period or vesting period). The Company accounts
for equity instruments issued to non-employees in accordance with the provisions of ASC 718 and ASC 505-50, “Equity Based
Payment to Non-Employees”. All transactions with non-employees, in which goods or services are the consideration received
for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value
of the equity instrument issued, whichever is more appropriately measurable.
The
exercise price of options granted under the Company’s stock option plan (the “Plan”) may not be less than the
fair market value on the date of grant. Stock options under the Plan may be awarded to officers, key employees, consultants and
non-employee directors of the Company. Generally, options outstanding vest over periods not exceeding four years and are exercisable
for up to five years from the grant date.
Share
based compensation expense recognized under ASC 718 for the three and nine months ended September 30, 2017 were $3,266 and $9,798,
respectively. Share based compensation expense recognized under ASC 718 for the three and nine months ended September 30, 2016
were $3,397 and $10,192, respectively. The share based compensation expense primarily represents the amortization of the fair
value of 1,000,000 restricted shares granted to the Company’s Chief Executive Officer on September 9, 2011 of $195,968,
after adjusting for the effect on the fair value of the stock options related to this transaction. The fair value will be amortized
over 15 years.
The
following summarizes stock option activity for the nine month period ended September 30, 2017:
|
|
Shares
|
|
|
Weighted
Average Exercise Price
|
|
|
Weighted
Average Remaining Contractual Term (in years)
|
|
|
Aggregate
Intrinsic Value
|
|
Outstanding
at December 31, 2016
|
|
|
28,000
|
|
|
$
|
2.10
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(7,000
|
)
|
|
|
2.92
|
|
|
|
|
|
|
|
|
|
Forfeited
or expired
|
|
|
(7,000
|
)
|
|
|
1.02
|
|
|
|
|
|
|
|
|
|
Outstanding
at September 30, 2017
|
|
|
14,000
|
|
|
$
|
2.23
|
|
|
|
1.25
|
|
|
$
|
10,513
|
|
Vested
and exercisable at September 30, 2017
|
|
|
14,000
|
|
|
$
|
2.23
|
|
|
|
1.25
|
|
|
$
|
10,513
|
|
On
July 31, 2014, in connection with the Company’s public offering in July 2014, the Company issued warrants to purchase up
to 87,719 common shares, with an exercise price of $3.5625 per common share, to the representative of the underwriters of the
offering (the “July 2014 Representative Warrants”). These warrants are exercisable at any time, and from time to time,
in whole or in part, commencing on July 28, 2015 and expire on July 28, 2019. The fair value of these warrants, using the Black-Scholes
option pricing model, on the date of issuance was $42,224. At September 30, 2017, July 2014 Representative Warrants to purchase
up to 4,000 common shares were outstanding.
On
May 29, 2015, in connection with the Company’s public offering in May 2015, the Company issued warrants to purchase up to
50,750 common shares, with an exercise price of $5.4875 per common share, to the representative of the underwriters of the offering
(the “May 2015 Rep Warrants”). These warrants are exercisable at any time, and from time to time, in whole or in part,
commencing on May 22, 2016 and expire on May 22, 2020. The fair value of these warrants, using the Black-Scholes option pricing
model, on the date of issuance was $54,928. At September 30, 2017, May 2015 Rep Warrants to purchase up to 19,031 common shares
were outstanding.
On
August 15, 2016, in connection with the Shelf Takedown (defined below), the Company issued warrants to purchase up to 33,612 common
shares, with an exercise price of $7.4375 per common share, to the representative of the underwriters of the offering (the “August
2016 Rep Warrants”). The warrants are exercisable at any time, and from time to time, in whole or in part, commencing on
August 9, 2017 and expire on August 9, 2021. The fair value of these warrants, using the Black-Scholes option pricing model, on
the date of issuance was $47,020. At September 30, 2017, all of the August 2016 Rep Warrants were outstanding.
7.
LOANS AND LINE OF CREDIT
Line
of Credit
On
February 27, 2015, the Company entered into the Credit and Security Agreement with Webster. The Webster Credit Line provided for
an interest rate (until amended – as described below) of either LIBOR plus 4.75% or the base commercial lending rate of
Webster plus 3.25% as chosen by the Company for each drawdown. The Webster Credit Line contains various covenants and restrictions
including, among other covenants and restrictions, limiting the amount that the Company can borrow relative to the value of the
underlying collateral, maintaining various financial ratios and limitations on the terms of loans the Company makes to its customers,
limiting the Company’s ability to pay dividends under certain circumstances, and limiting the Company’s ability to
repurchase its common shares, sell assets, engage in mergers or consolidations, grant liens, and enter into transactions with
affiliates. In addition, the Webster Credit Line also contains a cross default provision which will deem any default under any
indebtedness owed by us or our subsidiary, MBC Funding II, as a default under the credit line. Mr. Assaf Ran, the Company’s
President and Chief Executive Officer, had personally guaranteed all of the Company’s obligations to Webster.
Effective
July 7, 2017, the Company entered into Amendment No. 3 to Credit and Security Agreement and Amendment No. 1 to Guaranty Agreement
(the “Amendment”), with Webster. In conjunction with the execution of the Amendment, the Company also entered into
an Amended and Restated Revolving Credit Note (the “Amended Note”), and Amendment No. 3 Fee Letter (the “Fee
Letter”), each dated July 7, 2017, with Webster. Pursuant to the terms of the Amendment, the Webster Credit Line was increased
by $1 million to $15 million in the aggregate, with an option, at the discretion of Webster, to increase the Webster Credit Line
to $20 million in the aggregate. The term of the Webster Credit Line was extended to February 28, 2021, unless sooner terminated,
and contains a provision that permits a Company option for a further extension of the Webster Credit Line until February 28, 2022,
subject to Webster’s consent. Pursuant to the terms of the Amendment, the terms of the personal guaranty provided by Mr.
Ran were amended such that the potential sums owed under Mr. Ran’s personal guaranty will not exceed the sum of $500,000
plus any costs relating to the enforcement of the personal guaranty.
In
addition, the interest rates relating to the Webster Credit Line were amended such that the interest rates now equal (i) LIBOR
plus 3.75% plus the 0.5% Agency Fee (as hereinafter defined) or (ii) a Base Rate (as defined in the Credit and Security Agreement)
plus 2.25% plus the 0.5% Agency Fee, as chosen by the Company for each drawdown. Finally, the Amendment provides that the Company
shall not permit mortgage loans that are outstanding more than 24 months after their origination date to comprise more than 17.5%
of their total portfolio of mortgage loans at any time. Pursuant to the terms of the Fee Letter, the Company agreed to pay Webster
an agency fee equal to 0.5% per annum (the “Agency Fee”) on the actual principal amount of advances outstanding during
any month, as well as a $15,000 syndication fee.
On
August 8, 2017, the Company entered into the Amended Credit Agreement with Webster and Flushing. In conjunction with the execution
of the Amended Credit Agreement, the Company also entered into a Revolving Credit Note in the principal aggregate amount of $5
million with Flushing (the “Flushing Note”) and an Amended and Restated Fee Letter (the “Amended Fee Letter”)
with Webster, each dated August 8, 2017.
Pursuant
to the terms of the Amended Credit Agreement, the Company’s existing Webster Credit Line was amended to include Flushing
as an additional lender, as well as increased the funds available under the Webster Credit Line by $5 million, to $20 million
in the aggregate. The Amended Credit Agreement was further amended and restated to incorporate previously reported amendments.
In addition, Mr. Ran executed an Amended and Restated Guaranty, which was restated to include previously reported amendments.
Finally, the Company executed the Amended Fee Letter which incorporated previously reported amendments.
The
Company was in compliance with all covenants of the Webster Credit Line as of September 30, 2017. At September 30, 2017, the outstanding
amount under the Webster Credit Line was $16,174,495. The interest rate on the amount outstanding fluctuates daily. The rate,
including the 0.5% Agency Fee, for September 30, 2017 was 5.485%.
Total
costs to establish the Webster Credit Line were approximately $144,000, and the total costs to amend the Webster Credit Line were
approximately $43,000. These costs are being amortized over the term of the respective agreement, using the straight-line method.
The amortization costs for the nine months ended September 30, 2017 and 2016 were $39,064 and $36,124, respectively.
Short-term
Loans
During
the third quarter of 2017, Mr. Ran, the CEO of the Company, made two bridge loans to the Company in the aggregate amount
of $860,000, at an interest rate of 6%, per annum. As of August 8, 2017, both loans were repaid in full. The interest expense
for these loans amounted to an aggregate of $923 for the quarter ended September 30, 2017.
8.
SENIOR SECURED NOTES
On
April 25, 2016, in an initial public offering, MBC Funding II issued 6% senior secured notes, due April 22, 2026 (the “Notes”)
in the aggregate principal amount of $6,000,000 under the Indenture, dated April 25, 2016, among MBC Funding II, as Issuer, the
Company, as Guarantor, and Worldwide Stock Transfer LLC, as Indenture Trustee (the “Indenture”). The Notes, having
a principal amount of $1,000 each, are listed on the NYSE MKT and trade under the symbol “LOAN/26”. Interest accrues
on the Notes commencing on May 16, 2016. The accrued interest is payable monthly in cash, in arrears, on the 15th day of each
calendar month commencing June 2016.
Under
the terms of the Indenture, the aggregate outstanding principal balance of the mortgage loans held by MBC Funding II, together
with MBC Funding II’s cash on hand, must always equal at least 120% of the aggregate outstanding principal amount of the
Notes at all times. To the extent the aggregate principal amount of the mortgage loans owned by MBC Funding II plus MBC Funding
II’s cash on hand is less than 120% of the aggregate outstanding principal balance of the Notes, MBC Funding II is required
to repay, on a monthly basis, the principal amount of the Notes equal to the amount necessary such that, after giving effect to
such repayment, the aggregate principal amount of all mortgage loans owned by MBC Funding II plus MBC Funding II’s cash
on hand at such time is equal to or greater than 120% of the outstanding principal amount of the Notes. For this purpose, each
mortgage loan is deemed to have a value equal to its outstanding principal balance, unless the borrower is in default of its obligations.
MBC
Funding II may redeem the Notes, in whole or in part, at any time after April 22, 2019 upon at least 30 days prior written notice
to the Noteholders. The redemption price will be equal to the outstanding principal amount of the Notes redeemed plus the accrued
but unpaid interest thereon up to, but not including, the date of redemption, without penalty or premium; provided that (i) if
the Notes are redeemed on or after April 22, 2019 but prior to April 22, 2020, the redemption price will be 103% of the principal
amount of the Notes redeemed and (ii) if the Notes are redeemed on or after April 22, 2020 but prior to April 22, 2021, the redemption
price will be 101.5% of the principal amount of the Notes redeemed plus, in either case, the accrued but unpaid interest on the
Notes redeemed up to, but not including, the date of redemption.
Each
noteholder has the right to cause MBC Funding II to redeem his, her, or its Notes on April 22, 2021. The redemption price will
be equal to the outstanding principal amount of the Notes redeemed plus the accrued but unpaid interest up to, but not including,
the date of redemption, without penalty or premium. In order to exercise this right, the Noteholder must notify MBC Funding II,
in writing, no earlier than November 22, 2020 and no later than January 22, 2021. All notes that are subject to a properly and
timely notice will be redeemed on April 22, 2021. Any noteholder who fails to make a proper and timely election will be deemed
to have waived his, her or its right to have his, her or its Notes redeemed prior to the maturity date.
MBC
Funding II is obligated to offer to redeem the Notes if there occurs a “change of control” with respect to MBC Funding
II or the Company or if MBC Funding II or the Company sell any assets unless, in the case of an asset sale, the proceeds are reinvested
in the business of the seller. The redemption price in connection with a “change of control” will be 101% of the principal
amount of the Notes redeemed plus accrued but unpaid interest thereon up to, but not including, the date of redemption. The redemption
price in connection with an asset sale will be the outstanding principal amount of the Notes redeemed plus accrued but unpaid
interest thereon up to, but not including, the date of redemption.
9.
PUBLIC OFFERING
As
mentioned above, on April 25, 2016, MBC Funding II completed a firm commitment underwritten public offering of the Notes. The
Company guaranteed MBC Funding II’s obligations under the Notes, which are secured by a pledge by the Company of 100% of
the outstanding common shares of MBC Funding II it owns. The gross proceeds to MBC Funding II from this offering were $6,000,000,
and the net proceeds were approximately $5,200,000, after deducting the underwriting discounts and commissions and other offering
expenses. MBC Funding II utilized the proceeds to purchase a pool of mortgage loans from MBC, which the Company in turn used to
pay down the Webster Credit Line (see Note 7). The Company’s Chief Executive Officer and Chief Financial Officer also serve
as the Chief Executive Officer and Chief Financial Officer, respectively, of MBC Funding II. In connection with the initial public
offering of MBC Funding II, MBC Funding II’s Chief Executive Officer purchased approximately $594,000 of the senior secured
Notes and MBC Funding II’s Chief Financial Officer purchased approximately $38,000 of the senior secured Notes. Subsequent
to the offering, MBC Funding II’s Chief Financial Officer purchased an additional $70,000 of the senior secured Notes.
On
August 15, 2016, the Company completed a public offering of 672,269 common shares at an offering price of $5.95 per share (the
“Shelf Takedown”). The gross proceeds raised by the Company from the Shelf Takedown were approximately $4,600,000
(including approximately $600,000 from the sale of 100,840 additional common shares upon the exercise of the over-allotment option
by the underwriter) before deducting underwriting discounts and commissions and other offering expenses. The total net proceeds
from the Shelf Takedown were approximately $4,200,000.
10.
COMMITMENTS AND CONTINGENCIES
Operating
Lease
On
June 9, 2011, the Company entered into a new lease agreement (the “Lease’) to relocate its corporate headquarters
to 60 Cutter Mill Road, Great Neck, New York. The Lease was for a term of five years and two months commencing June 2011 and ending
August 2016. The rent increased annually during the term and ranged from approximately $2,800 per month during the first year
to approximately $3,200 per month during the fifth year.
On
July 21, 2016, the Company amended the Lease (the “Lease Amendment”) to extend the term of the Lease for an additional
five years, through September 30, 2021. Among other things, the Lease Amendment provides for gradual annual rent increases from
approximately $3,500 per month during the first year to $3,900 per month during the fifth year of the extension term.
11. RECLASSIFICATIONS
During
the quarter ended June 30, 2017, management determined to adopt an unclassified balance sheet format for financial statement reporting
purposes in order to be consistent with common practice in the Real Estate Investment Trust (REIT) industry. Certain reclassifications
have been made to the classified balance sheet as of December 31, 2016 to conform to the current period’s presentation.
********
Item
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with our
unaudited consolidated financial statements and notes thereto included in this Quarterly Report on Form 10-Q. The discussion and
analysis contains forward-looking statements based on current expectations that involve risks and uncertainties. Actual results
and the timing of certain events may differ significantly from those projected in such forward-looking statements
.
We
are a New York-based real estate finance company that specializes in originating, servicing and managing a portfolio of first
mortgage loans. We offer short-term, secured, non-banking loans (sometimes referred to as “hard money” loans), which
we may renew or extend on, before or after their initial term expires, to real estate investors to fund their acquisition, renovation,
rehabilitation or development of residential or commercial properties located in the New York metropolitan area.
The
properties securing the loans are generally classified as residential or commercial real estate and, typically, are not income
producing. Each loan is secured by a first mortgage lien on real estate. In addition, each loan is personally guaranteed by the
principal(s) of the borrower, which guarantee may be collaterally secured by a pledge of the guarantor’s interest in the
borrower. The face amount of the loans we originate historically ranged from $14,000 to a maximum of $2 million. Our lending policy
limits the maximum amount of any loan to the lower of (i) 9.9% of the aggregate amount of our loan portfolio (not including the
loan under consideration) and (ii) $2 million. Our loans typically have a maximum initial term of 12 months bearing interest at
a fixed rate of 11% to 14% per year. In addition, we usually receive origination fees or “points” ranging from 0%
to 3% of the original principal amount of the loan as well as other fees relating to underwriting and funding the loan. Interest
is always payable monthly, in arrears. In the case of acquisition financing, the principal amount of the loan usually does not
exceed 75% of the value of the property (as determined by an independent appraiser) and in the case of construction financing,
it is typically up to 80% of construction costs.
Since
commencing this business in 2007, we have made over 570 loans and never foreclosed on a property. In addition, none of our loans
have ever gone into default, although sometimes we have renewed or extended our loans to enable the borrower to avoid premature
sale or refinancing of the property. When we renew or extend a loan we receive additional “points” and other fees.
Our
primary business objective is to grow our loan portfolio while protecting and preserving capital in a manner that provides for
attractive risk-adjusted returns to our shareholders over the long term through dividends. We intend to achieve this objective
by continuing to selectively originate loans and carefully manage our portfolio of first mortgage real estate loans in a manner
designed to generate attractive risk-adjusted returns across a variety of market conditions and economic cycles. We believe that
the demand for relatively small loans secured by residential and commercial real estate held for investment in the New York metropolitan
market is significant and growing and that traditional lenders, including banks and other financial institutions, that usually
address this market are unable to satisfy this demand. This demand/supply imbalance has created an opportunity for non-bank “hard
money” real estate lenders like us to selectively originate high-quality first mortgage loans on attractive terms and this
condition should persist for a number of years. We have built our business on a foundation of intimate knowledge of the New York
metropolitan area real estate market combined with a disciplined credit and due diligence culture that is designed to protect
and preserve capital. We believe that our flexibility in terms of meeting the needs of borrowers without compromising our standards
on credit risk, our expertise, our intimate knowledge of the New York metropolitan area real estate market and our focus on newly
originated first mortgage loans, has defined our success until now and should enable us to continue to achieve our objectives.
A
principal source of new transactions has been repeat business from prior customers and their referral of new business. We also
receive leads for new business from banks, brokers and a limited amount of advertising. Finally, our chief executive officer also
spends a significant portion of his time on new business development. We rely on our own employees, independent legal counsel,
and other independent professionals to verify titles and ownership, to file liens and to consummate the transactions. Outside
appraisers are used to assist us in evaluating the worth of collateral, when deemed necessary by management. We also use construction
inspectors.
For
the nine month periods ended September 30, 2017 and 2016 the total amounts of $30,314,500 and $24,299,500 have been lent, respectively,
offset by collections received from borrowers, under our commercial loans in the amount of $20,649,870 and $23,671,720, respectively.
At
September 30, 2017, we were committed to an additional $5,345,500 in construction loans that can be drawn by the borrowers when
certain conditions are met.
To
date, we have not experienced any defaults and none of the loans previously made have been non-collectable, although no assurances
can be given that existing or future loans may not go into default or prove to be non-collectible in the future.
We
satisfied all of the requirements to qualify as a REIT for federal income tax purposes and we qualified to be taxed as a REIT
commencing with our taxable year ended December 31, 2014. In order to maintain our qualification as a REIT and avoid any excise
tax on our net taxable income, we are required to distribute each year at least 90% of our taxable income to our shareholders
on an annual basis. If we distribute less than 100% of our taxable income (but more than 90%), the undistributed portion will
be taxed at the regular corporate income tax rates. As a REIT, we may also be subject to federal excise taxes and minimum state
taxes.
Results
of Operations
Three
Months Ended September 30, 2017 Compared to Three Months Ended September 30, 2016
Revenue
Total
revenues for the three month period ended September 30, 2017 were approximately $1,591,000 compared to approximately $1,169,000
for the three month period ended September 30, 2016, an increase of $422,000, or 36.1%. The increase in revenue represents an
increase in lending operations. For the three month periods ended September 30, 2017 and 2016, approximately $1,352,000 and $960,000,
respectively, of our revenues were attributable to interest income on the secured commercial loans that we offer to small businesses,
and approximately $240,000 and $209,000, respectively, of our revenues were attributable to origination fees on such loans. Our
loans are principally secured by collateral consisting of real property and, generally, accompanied by personal guarantees from
the principals of the borrowers.
Interest
and amortization of debt service costs
Interest
and amortization of debt service costs for the three month period ended September 30, 2017 was approximately $352,000 compared
to approximately $205,000 for the three month period ended September 30, 2016, an increase of $147,000, or 71.7%. The increase
in interest and amortization of debt service costs was primarily attributable to the use of the Webster Credit Line and the issuance
of the senior secured Notes (See Notes 7 and 8 to the financial statements included elsewhere in this report) in order to increase
our ability to make loans.
General
and administrative expenses
General
and administrative expenses for the three month period ended September 30, 2017 were approximately $267,000 compared to approximately
$237,000 for the three month period ended September 30, 2016, an increase of $30,000, or 12.7%. The increase is primarily attributable
to increases in travel, meals and payroll expenses, offset by a decrease in bank fees.
Write-down
of investment in privately held company
Write-down
of investment in privately held company for the three month periods ended September 30, 2017 and 2016 was $10,000 and $0, respectively.
We wrote down the value of our investment in a privately held company due to the fact that it has experienced delays in executing
its business plan (See Note 4 to the financial statements included elsewhere in this report).
Net
income
Net
income for the three month period ended September 30, 2017 was approximately $961,000 compared to approximately $725,000 for the
three month period ended September 30, 2016, an increase of $236,000, or 32.6%. The increase is primarily attributable to the
increase in revenue, offset by the increase in interest and amortization of debt service costs.
Nine
Months Ended September 30, 2017 Compared to Nine Months Ended September 30, 2016
Revenue
Total
revenues for the nine month period ended September 30, 2017 were approximately $4,322,000 compared to approximately $3,440,000
for the nine month period ended September 30, 2016, an increase of $882,000, or 25.6%. The increase in revenue represents an increase
in lending operations. For the nine month periods ended September 30, 2017 and 2016, revenues of approximately $3,647,000 and
$2,849,000, respectively, were attributable to interest income on the secured commercial loans that we offer to small businesses,
and approximately $675,000 and $591,000, respectively, were attributable to origination fees on such loans. Our loans are principally
secured by collateral consisting of real property and, generally, accompanied by personal guarantees from the principals of the
borrowers.
Interest
and amortization of debt service costs
Interest
and amortization of debt service costs for the nine month period ended September 30, 2017 were approximately $862,000 compared
to approximately $594,000 for the nine month period ended September 30, 2016, an increase of $268,000, or 45.1%. The increase
in interest and amortization of debt service costs was primarily attributable to the use of the Webster Credit Line and the issuance
of the senior secured Notes (See Notes 7 and 8 to the financial statements included elsewhere in this report) in order to increase
our ability to make loans.
General
and administrative expenses
General
and administrative expenses for the nine month period ended September 30, 2017 were approximately $843,000 compared to approximately
$698,000 for the nine month period ended September 30, 2016, an increase of $145,000, or 20.8%. The increase is primarily attributable
to bonuses to officers as well as increases in travel, meals and payroll expenses.
Write-down
of investment in privately held company
Write-down
of investment in privately held company for the nine month periods ended September 30, 2017 and 2016 was $20,000 and $10,000,
respectively. We wrote down the value of our investment in a privately held company due to the fact that it has experienced delays
in executing its business plan. (See Note 4 to the financial statements included elsewhere in this report).
Net
Income
Net
income for the nine month period ended September 30, 2017 was approximately $2,592,000 compared to approximately $2,130,000 for
the nine month period ended September 30, 2016, an increase of $462,000, or 21.7%. The increase is primarily attributable to the
increase in revenue, offset by the increase in operating costs.
Liquidity
and Capital Resources
At
September 30, 2017, we had cash and cash equivalents of approximately $112,000 compared to cash and cash equivalents of approximately
$96,000 at December 31, 2016.
For
the nine month periods ended September 30, 2017 and 2016, net cash provided by operating activities were approximately $2.6 million
and $2.3 million, respectively. The increase in net cash provided by operating activities primarily results from increases in
net income, amortization of deferred financing costs, and deferred origination fees, offset by an increase in interest receivable
on loans.
Net
cash used in investing activities for the nine month period ended September 30, 2017 was approximately $9.7 million as compared
to approximately $631,000 for the period ended September 30, 2016. Net cash used in investing activities for the nine month period
ended September 30, 2017 primarily consisted of the issuance of our short term commercial loans in the amount of approximately
$30.3 million, offset by collection of these loans in the amount of approximately $20.7 million. In the period ended September
30, 2016, net cash used in investing activities primarily consisted of the issuance of our short term commercial loans in the
amount of approximately $24.3 million, offset by collection of these loans in the amount of approximately $23.7 million.
Net
cash provided by financing activities for the nine month period ended September 30, 2017 was approximately $7.0 million as compared
to approximately $1.6 million used in financing activities for the period ended September 30, 2016. Net cash provided by financing
activities for the nine month period ended September 30, 2017 reflects the proceeds from the Webster Credit Line of approximately
$9.7 million and the proceeds from the exercise of options of approximately $20,000, offset by the dividend payment of approximately
$2.5 million, the purchase of treasury shares of approximately $172,000, and the deferred financing costs of approximately $43,000.
In the period ended September 30, 2016, net cash used in financing activities reflects the repayments of the Webster Credit Line
of approximately $7.6 million, the dividend payment of approximately $1.9 million, the repayments of short term loans of approximately
$1.1 million, and cash restricted for reduction of the line of credit of approximately $919,000, offset by the net proceeds from
the public offerings of approximately $9.5 million (including pertinent expenses of approximately $60,000 paid during 2015) and
the proceeds from the exercise of warrants of approximately $305,000. In addition, the Company received two bridge loans
in the aggregate amount of $860,000 from Mr. Ran, the CEO of the Company, during the process of increasing the Webster Credit
line (as described below). Both loans were received during the third quarter of 2017 and repaid in full as of August
8, 2017. The company does not anticipate requiring loans from Mr. Ran in the near future.
On
February 27, 2015, we entered into a Credit and Security Agreement with Webster pursuant to which we could initially borrow up
to $14 million until February 27, 2018 against assignments of mortgages and other collateral. Until July 7, 2017, the Webster
Credit Line provided for an interest rate of either LIBOR plus 4.75% or the base commercial lending rate of Webster plus 3.25%
as chosen by us for each drawdown. The Webster Credit Line contains various covenants and restrictions, including limiting the
amount that we can borrow relative to the value of the underlying collateral, maintaining various financial ratios and limitations
on the terms of loans we make to our customers. In addition, the Webster Credit Line also contains a cross default provision which
will deem any default under any indebtedness owed by us or our subsidiary, MBC Funding II, as a default under the credit line.
Mr. Assaf Ran, our Chief Executive Officer, had personally guaranteed all of our obligations to Webster.
Effective
July 7, 2017, we entered into the Amendment with Webster. In conjunction with the execution of the Amendment, the Company also
entered into Amended Note and the Fee Letter, each dated July 7, 2017, with Webster. Pursuant to the terms of the Amendment, the
Webster Credit Line was increased by $1 million to $15 million in the aggregate, with an option, at the discretion of Webster,
to increase the Webster Credit Line to $20 million in the aggregate. The term of the Webster Credit Line was extended to February
28, 2021, unless sooner terminated, and contains a provision that permits a Company option for a further extension of the Webster
Credit Line until February 28, 2022, subject to Webster’s consent. Pursuant to the terms of the Amendment, the terms of
the personal guaranty provided by Mr. Ran were amended such that the potential sums owed under Mr. Ran’s personal guaranty
will not exceed the sum of $500,000 plus any costs relating to the enforcement of the personal guaranty.
In
addition, the interest rates relating to the Webster Credit Line were amended such that the interest rates now equal (i) LIBOR
plus 3.75% plus the 0.5% Agency Fee or (ii) a Base Rate (as defined in the Credit and Security Agreement) plus 2.25% plus the
0.5% Agency Fee, as chosen by the Company for each drawdown. Finally, the Amendment provides that the Company shall not permit
mortgage loans that are outstanding more than 24 months after their origination date to comprise more than 17.5% of their total
portfolio of mortgage loans at any time. Pursuant to the terms of the Fee Letter, the Company agreed to pay Webster an agency
fee equal to 0.5% per annum on the actual principal amount of advances outstanding during any month, as well as a $15,000 syndication
fee.
On
August 8, 2017, we entered into the Amended Credit Agreement with Webster and Flushing. In conjunction with the execution of the
Amended Credit Agreement, we also entered into the Flushing Note in the principal aggregate amount of $5 million with Flushing
and the Amended Fee Letter with Webster, each dated August 8, 2017. Pursuant to the terms of the Amended Credit Agreement, the
Company’s existing Webster Credit Line was amended to include Flushing as an additional lender, as well as increased the
funds available under the Webster Credit Line by $5 million, to $20 million in the aggregate. The Amended Credit Agreement was
further amended and restated to incorporate previously reported amendments. In addition, Mr. Ran executed an Amended and Restated
Guaranty, which was restated to include previously reported amendments. Finally, the Company executed the Amended Fee Letter which
incorporated previously reported amendments.
We
were in compliance with all covenants of the Webster Credit Line as of September 30, 2017. At September 30, 2017, the outstanding
amount under the Webster Credit Line was $16,174,495. The interest rate on the amount outstanding fluctuates daily. The rate,
including the 0.5% Agency Fee, for September 30, 2017 was 5.485%.
On
April 25, 2016, MBC Funding II, our wholly owned subsidiary, completed an underwritten public offering of the Notes. We guaranteed
MBC Funding II’s obligations under the Notes, which are secured by our pledge of 100% of the outstanding common shares of
MBC Funding II we own. The gross proceeds to MBC Funding II from this offering were $6.0 million, and the net proceeds were approximately
$5.2 million, after deducting the underwriting discounts and commissions and other offering expenses (See Notes 8 and 9 to the
financial statements included elsewhere in this report). MBC Funding II utilized the proceeds to purchase a pool of mortgage loans
from us, which we in turn used to pay down the Webster Credit Line.
On
August 15, 2016, we completed a public offering of 672,269 common shares. In addition, the underwriter fully exercised its over-allotment
option for an additional 100,840 common shares. The gross proceeds from the offering, including the exercise of the over-allotment
option, were approximately $4.6 million and the net proceeds were approximately $4.2 million, after deducting our underwriting
discounts and commissions and offering expenses. Net proceeds from this offering were used to increase our loan portfolio and
for working capital and general corporate purposes.
On
March 14, 2017, our Board of Directors authorized a share buy back program (the “Share Buy Back Program”), pursuant
to which we may, from time to time, purchase up to 100,000 shares of our common stock. The Share Buy Back Program does not obligate
the Company to purchase any shares and expires in 12 months. The authorization for the Share Buy Back Program may be terminated,
increased or decreased by the Company’s Board of Directors in its discretion at any time. To date, we have purchased 33,102
shares of the Company’s common stock for an aggregate of $172,156 pursuant to the Share Buy Back Program. During the quarter
ended September 30, 2017, we did not purchase any of our shares pursuant to the Share Buy Back Program.
We
anticipate that our current cash balances and the Webster Credit Line, as described above, together with our cash flows from operations
will be sufficient to fund our operations for the next 12 months. However, we expect our working capital requirements to increase
over the next 12 months as we continue to strive for growth.
Changes
to Critical Accounting Policies and Estimates
Our
critical accounting policies and estimates are set forth in our Annual Report on Form 10-K for the fiscal year ended December
31, 2016.